🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

42 results for “The University of Hong Kong” Clear

  1. 25% AgNO3 solution followed by 5% NaF

    The University of Hong Kong

    Early Childhood Caries

    phase 3 small molecule completed

    1 trial

  2. 3-second SDF application

    The University of Hong Kong

    Early Childhood Caries

    phase 3 other completed

    1 trial

  3. Acupuncture (Procedure)

    The University of Hong Kong

    Autistic Disorder

    phase 3 other completed

    1 trial

  4. Masticatory muscle training exerciser

    The University of Hong Kong

    Mastication

    phase 3 other active

    1 trial

  5. SDF solution

    The University of Hong Kong

    Dental Caries

    phase 3 other completed

    1 trial

  6. Vortioxetine

    The University of Hong Kong

    Cannabis Use Disorder

    phase 3 small molecule completed

    1 trial

  7. Atezolizumab

    The University of Hong Kong

    NSCLC Stage IIIB

    phase 2 small molecule active

    1 trial

  8. Bomedemstat

    The University of Hong Kong

    Myelofibrosis

    phase 2 small molecule active

    1 trial

  9. Capecitabine

    The University of Hong Kong

    Pancreatic Adenocarcinoma

    phase 2 small molecule completed

    1 trial

  10. Dapagliflozin 10mg Tab

    The University of Hong Kong

    Lupus Nephritis

    phase 2 small molecule active

    1 trial

  11. Decitabine

    The University of Hong Kong

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  12. Dietary

    The University of Hong Kong

    Colorectal Cancer

    phase 2 other active

    1 trial

  13. Interferon Beta-1B

    The University of Hong Kong

    COVID

    phase 2 small molecule completed

    1 trial

  14. Oral arsenic trioxide

    The University of Hong Kong

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  15. Traditional Chinese acupuncture

    The University of Hong Kong

    Phonotraumatic Injuries

    phase 2 other active

    1 trial

  16. pembrolizumab

    The University of Hong Kong

    T-Cell Lymphoma

    phase 2 small molecule active

    1 trial

  17. Folic Acid 5 MG

    The University of Hong Kong

    Acute Kidney Injury

    phase 1 small molecule active

    1 trial

  18. Alcohol injection

    The University of Hong Kong

    Malignancy

    approved small molecule active

    1 trial

  19. Atosiban

    The University of Hong Kong

    Subfertility

    approved small molecule completed

    1 trial

  20. Brolucizumab

    The University of Hong Kong

    Age-Related Macular Degeneration

    approved small molecule completed

    1 trial

  21. Bupivacaine Injection [Marcaine]

    The University of Hong Kong

    Acute Pain

    approved small molecule completed

    1 trial

  22. Cinacalcet

    The University of Hong Kong

    Kidney Failure

    approved small molecule completed

    1 trial

  23. Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy

    The University of Hong Kong

    Fontan

    approved small molecule active

    1 trial

  24. Dexamethasone

    The University of Hong Kong

    Total Knee Replacement

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources